Uci Health-Orange
101 City Drive South, Orange, CA, 92868 · (714) 456-7890
$2.54B
Net patient revenue, FY 2025
$2.54B
Net patient revenue, FY 2025
Beds
911
FY 2025
Star rating
4 of 5
Patient survey: 2 of 5
Net patient revenue
$2.54B
FY 2025
Net income
-$155.7M
Patient care margin -6.1%
Discharges
30,155
Occupancy 92.1%
Clinicians
2,627
Medicare clinicians who work here
Finances and location
Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is
Revenue and expenses by fiscal year
4 hospitals in the system. Zoom, drag, or use the buttons.
Financials by fiscal year
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $2.54B | $2.70B | -6.1% | -$155.7M | 30,155 | $29.1M | 20.8% | 5.8% |
| 2024 | $2.09B | $2.26B | -8.2% | -$1.5M | 24,056 | $46.7M | 20.4% | 8.2% |
| 2023 | $1.90B | $1.94B | -2.5% | $131.2M | 22,163 | $45.2M | 19.3% | - |
| 2022 | $1.66B | $1.76B | -6.2% | $28.7M | 22,651 | $29.7M | 20.2% | 19.2% |
| 2021 | $1.47B | $1.56B | -6.5% | $155.1M | 20,675 | $38.4M | 19.4% | 15.3% |
| 2020 | $1.30B | $1.51B | -15.8% | -$56.5M | 19,931 | $37.0M | 19.2% | 18.7% |
Quality of care
Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.
Death rates
| Death rate after heart bypass surgery | 3.3% | US median 2.3% |
| Death rate for COPD patients | 7.2% | US median 8.5% |
| Death rate for heart attack patients | 12.2% | US median 11.8% |
| Death rate for heart failure patients | 10.3% | US median 11% |
| Hospital-wide death rate within 30 days | 3% | US median 3.9% |
| Death rate for pneumonia patients | 15.1% | US median 15.2% |
| Death rate for stroke patients | 10.4% | US median 11.6% |
Readmissions
| Readmission rate after heart bypass surgery | 12.9% | US median 10.9% |
| Readmission rate for COPD | 21% | US median 19.8% |
| Readmission rate after a heart attack | 14.6% | US median 14.4% |
| Readmission rate for heart failure | 20.8% | US median 21.3% |
| Readmission rate after hip or knee replacement | 5.8% | US median 5.8% |
| Readmission rate for pneumonia | 16.8% | US median 17.2% |
Patient safety
| Complications after hip or knee replacement | 3.5% | US median 4.1% |
| Serious complications (patient safety composite) | 0.90 | US median 0.96 |
Infections
| C. diff intestinal infections (ratio to expected) | 0.55 | US median 0.28 · better |
| Central line bloodstream infections (ratio to expected) | 0.56 | US median 0.48 · better |
| Surgical site infections after colon surgery (ratio to expected) | 0.45 | US median 0.72 · better |
| Surgical site infections after hysterectomy (ratio to expected) | 0.55 | US median 0.81 |
| MRSA bloodstream infections (ratio to expected) | 0.36 | US median 0.60 · better |
| Catheter urinary tract infections (ratio to expected) | 0.42 | US median 0.40 · better |
Patient survey
| Doctors always communicated well | 74% | US median 79% |
| Nurses always communicated well | 72% | US median 80% |
| Patient survey summary star rating | 2 of 5 | US median 3 of 5 |
| Area around the room always quiet at night | 40% | US median 59% |
| Patients who rated the hospital 9 or 10 out of 10 | 65% | US median 72% |
| Room and bathroom always clean | 62% | US median 73% |
| Patients who would definitely recommend the hospital | 67% | US median 71% |
Timely and effective care
| Patients who left the emergency department before being seen | 2% | US median 1% |
| Median time in the emergency department before leaving (minutes) | 318 min | US median 148 min |
| Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge | 16% | US median 15% |
| Patients who got appropriate care for severe sepsis and septic shock | 66% | US median 65% |
| Healthcare workers given the flu vaccine | 74% | US median 79% |
Hospital profile
- Medicare certification number (CCN)
- 050348
- Organization NPI
- 1689608150
- Legal name
- University of California Irvine
- County
- Orange County, CA
- Ownership
- Government (local)
- Teaching
- Major teaching
- In Medicare since
- 1976
- Full-time employees
- 7,584
- Health system
- University of California Health
Clinicians who work here
Medicare clinicians who list this hospital, by specialty
Specialties
Other University of California Health hospitals
| Hospital | Place |
|---|---|
| UC San Diego Health Hillcrest - Hillcrest Med Ctr | San Diego, CA |
| Ronald Reagan UCLA Medical Center | Los Angeles, CA |
| Resnick Neuropsychiatric Hospital at UCLA | Los Angeles, CA |
Other hospitals in Orange
Similar short-term acute care hospitals in California
Closest in number of beds
| Hospital | Place | Beds |
|---|---|---|
| Cedars-Sinai Medical Center | Los Angeles, CA | 913 |
| UCSF Medical Center | San Francisco, CA | 887 |
| Community Regional Medical Center | Fresno, CA | 783 |
| Santa Clara Valley Medical Center | San Jose, CA | 1,060 |
| Sharp Memorial Hospital | San Diego, CA | 745 |
| Stanford Health Care | Stanford, CA | 717 |
Medicare hospital stays
Inpatient stays by diagnosis related group (DRG), 2024
| Diagnosis group | Stays | Average charge | Medicare pays per stay | All hospitals |
|---|---|---|---|---|
| DRG 871 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC | 423 | $131,658.86 | $27,059.05 | $15,524.21 |
| DRG 291 HEART FAILURE AND SHOCK WITH MCC | 137 | $96,845.31 | $17,915.49 | $10,022.34 |
| DRG 872 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MCC | 89 | $61,536.63 | $13,772.80 | $7,681.44 |
| DRG 640 MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC | 86 | $96,209.66 | $18,591.94 | $10,642.23 |
| DRG 470 MAJOR HIP AND KNEE JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MCC | 73 | $115,370.44 | $24,262.42 | $14,289.25 |
| DRG 698 OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC | 62 | $93,225.65 | $21,729.79 | $13,076.55 |
| DRG 177 RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MCC | 57 | $111,870.51 | $20,786.56 | $12,667.88 |
| DRG 266 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITH MCC | 55 | $226,822.82 | $86,551.04 | $52,994.82 |
| DRG 853 INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURES WITH MCC | 54 | $454,389.46 | $90,024.06 | $40,556.82 |
| DRG 274 PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES WITHOUT MCC | 52 | $144,347.46 | $42,214.04 | $24,748.54 |
| DRG 330 MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH CC | 52 | $149,601.44 | $30,649.58 | $18,026.21 |
| DRG 025 CRANIOTOMY AND ENDOVASCULAR INTRACRANIAL PROCEDURES WITH MCC | 50 | $402,677.14 | $76,360.98 | $37,824.45 |
| DRG 064 INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH MCC | 49 | $119,311.45 | $23,597.55 | $15,695.20 |
| DRG 267 ENDOVASCULAR CARDIAC VALVE REPLACEMENT AND SUPPLEMENT PROCEDURES WITHOUT MCC | 46 | $180,573.65 | $66,893.26 | $40,566.75 |
| DRG 682 RENAL FAILURE WITH MCC | 45 | $107,012.40 | $20,992.44 | $11,457.18 |
Medicare outpatient services
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5491 Level 1 Intraocular Procedures | 1,628 | 1,017 | $2,275.70 | $1,751.67 |
| APC 5372 Level 2 Urology and Related Services | 815 | 477 | $636.98 | $502.15 |
| APC 8011 Comprehensive Observation Services | 800 | 744 | $2,667.41 | $2,090.36 |
| APC 5302 Level 2 Upper GI Procedures | 661 | 589 | $1,859.50 | $1,444.50 |
| APC 5373 Level 3 Urology and Related Services | 534 | 441 | $1,904.94 | $1,516.28 |
| APC 5503 Level 3 Extraocular, Repair, and Plastic Eye Procedures | 466 | 417 | $2,277.39 | $1,780.31 |
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 427 | 397 | $1,543.93 | $1,219.56 |
| APC 5153 Level 3 Airway Endoscopy | 427 | 269 | $1,456.99 | $1,264.08 |
| APC 5492 Level 2 Intraocular Procedures | 420 | 348 | $3,937.36 | $3,116.50 |
| APC 5375 Level 5 Urology and Related Services | 310 | 286 | $5,041.80 | $3,917.51 |
| APC 5431 Level 1 Nerve Procedures | 248 | 189 | $1,277.43 | $1,406.61 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 237 | 182 | $2,722.34 | $2,141.49 |
Payments from drug and device companies
Payments drug and device companies reported to this hospital
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 40 | $2.8M |
| Pfizer Inc. | 100 | $1.9M |
| Janssen Research & Development, LLC | 123 | $1.6M |
| AstraZeneca Pharmaceuticals LP | 21 | $1.5M |
| Genentech, Inc. | 78 | $1.5M |
| Amgen Inc. | 25 | $1.1M |
| Abbvie Inc. | 113 | $1.0M |
| AstraZeneca UK Limited | 5 | $798K |
| Novo Nordisk AS | 7 | $766K |
| E.R. Squibb & Sons, L.L.C. | 13 | $682K |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.